NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TriNetX

TriNetX

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://trinetx.com/

Last Round

Buyout/LBO

Sep 21, 2020

Total Funding Raised

$68.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

TriNetX is a healthcare technology company that operates a global health research network to enhance clinical trial design and recruitment through the integration of EMR data and clinical documentation.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Healthcare Analytics, Vertical SaaS, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

clinical trial softwarereal-world evidenceRWEpatient recruitmentclinical trial techclinical data platformprotocol feasibilityclinical trial recruitmenthealth research networksite selectionclinical trial marketplaceclinical trial innovationhealth data exchangeDaaSdata as a serviceclinical trial AIclinical trial analyticstrial design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TriNetX Comparables

Compare TriNetX with similar companies based on industry and business-model similarity.

TriNetX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
nference
83%
OM1
83%
HealthVerity
83%

TriNetX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOSep 21, 2020
Series DMar 13, 2019
Series AJun 1, 2015
Series BJun 1, 2015

TriNetX Investors

Notable investors and investment history

TriNetX investors
InvestorRounds
Deerfield ManagementSeries B, Series D
MPM CapitalSeries B, Series D, Series A
ITOCHU Technology VenturesSeries D
ITOCHU Technology VenturesSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 55% MoM.

  • Apr 7, 2026

    Acquired key assets from current partner Zetta Genomics.

TriNetX Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TriNetX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TriNetX's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range277
Year Founded2013
Last FundingSep 21, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.